AP NEWS

Global Blood-Brain Barrier Market 2016-2018 & 2026 - ResearchAndMarkets.com

September 24, 2018

DUBLIN--(BUSINESS WIRE)--Sep 24, 2018--The “Global Blood-Brain Barrier Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026” report has been added to ResearchAndMarkets.com’s offering.

The blood brain barrier market was valued at USD 496.4 Mn in 2016, and is expected to reach USD 5,704.2 Mn by 2026, expanding at a CAGR of 25.0% from 2018 to 2026.

The blood-brain barrier (BBB) plays important role in protecting the brain from toxic compounds and blood-borne disorders. Thus, in case of central nervous system diseases it is vital to get treatments across this barrier and deliver desired effect at targeted location. According to experts, more than 98% of small molecules drugs and nearly 100% of larger biologic drugs cannot enter the brain at adequate concentrations to project therapeutic effects.The three main BBB permeation mechanisms that occur are passive diffusion, endocytosis, and active transport. Passive diffusion occurs by two mechanisms free and facilitated, endocytosis occurs by bulk phase and facilitated, and active transport through influx and efflux. Technological development has introduced several key approaches for brain targeting include transport mechanisms such as cell-mediated endocytosis, reticence of active efflux pumps, adsorptive-mediated transcytosis, receptor-mediated transport, and the use of peptide vectors. Drug delivery technologies comprise delivery with assistance of liposomes, nanoparticles, nanogels, dendrimers, nanoemulsions, micelles, exosomes, polymersomes, and quantum dots.

Key Market Movements

Rising prevalence of neurological diseases coupled with rise in treatment limitations associated with blood-brain barrierIncessant growth in research and development activities carried out in BBB technologies market

Key Topics Covered:

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Global Blood-Brain Barrier Market: Market Dynamics and Future Outlook

Chapter 4. Global Blood-Brain Barrier Market, by Disease Type, 2016 - 2026 (US$ Mn)

Chapter 5. Global Blood-Brain Barrier Market, By Technology, 2016 - 2026 (US$)

Chapter 6. Global Blood-Brain Barrier Market: Pipeline Analysis

Chapter 7. Global Blood-Brain Barrier Market, by Geography, 2016 - 2026 (US$ Mn)

Chapter 8. Company Profiles

Allon Therapeutics, Inc.Angiochem Inc.Armagen Technologies, Inc.BrainsGateBristol-Myers SquibbBiOasis Technologies, Inc.Cephalon Inc.CerecorCarTheraCytos Biotechnology AGEnvivo Pharmaceuticals, Inc.Eli Lilly And CompanySanofi GenzymeIproteos S.L.Janssen Pharmaceutica NVNanomericsOssianix, Inc.Protheragen, Inc.F. Hoffman La-RocheShire plcFor more information about this report visit https://www.researchandmarkets.com/research/5hp5f7/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180924005435/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Hematological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/24/2018 07:04 AM/DISC: 09/24/2018 07:04 AM

http://www.businesswire.com/news/home/20180924005435/en

AP RADIO
Update hourly